Navigation Links
CryoCath to Hold First Quarter 2008 Conference Call and Webcast
Date:2/7/2008 Toronto Stock Exchange Symbol: CYT

MONTREAL, Feb. 7 /PRNewswire-FirstCall/ - CryoCath (TSX: CYT), will hold a conference call to discuss its first quarter 2008 financial results at 4:30 p.m. (Eastern Time) on Thursday, February 14, 2008. The Company will report its results in a press release to be issued at 4:00 p.m. on Thursday, February 14.

DATE: Thursday, February 14, 2008

TIME: 4:30 p.m., Eastern Standard Time

TAPED REPLAY: 416-640-1917 or 1-877-289-8525 (Available until

February 21, 2008)


WEBCAST: A live audio webcast of the call will be available at Webcast attendees are welcome to

listen to the conference in real-time or on-demand at

their convenience. The webcast will be archived for

365 days. Please connect to this website at least

15 minutes prior to the conference call to ensure

adequate time for any software download that may be

needed to hear the webcast.

About CryoCath

CryoCath - - is a medical technology company that leads the world in cryotherapy products to treat cardiovascular disease. With a priority focus on providing physicians with a complete solution of catheter products to treat cardiac arrhythmias, CryoCath has multiple products approved in the U.S., across Europe and several ROW countries. The Company is developing additional products to expand its pipeline of products to treat cardiac arrhythmias.

This press release includes "forward-looking statements" that are subject to risks and uncertainties, including with respect to the timing of regulatory trials and their outcome. For information identifying legislative or regulatory, economic, climatic, currency, technological, competitive and other important factors that could cause actual results to differ materially from those anticipated in the forward looking statements, see CryoCath's annual report available at under the heading Risks and Uncertainties in the Management's Discussion and Analysis section.

SOURCE CryoCath Technologies Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. CryoCath intends to contest patent infringement claim by CryoCor, Inc.
2. CryoCath announces 2007 fourth quarter and fiscal year end financial results
3. CryoCath to present at Piper Jaffray and BMO Healthcare conferences
4. CryoCath to present at CIBC Healthcare Conference
5. CryoCath files patent infringement lawsuit
6. PetFirst: Pet Insurance To Be More Popular in 2008
7. Nile Therapeutics Announces Dosing of First Heart Failure Patient in Phase Ib Study of CD-NP
8. The Female Health Company Schedules First Quarter Conference Call for February 13, 2008
9. First 90 Days After Stopping Plavix Most Dangerous
10. R Baby Foundation Raises $2.5 Million in First Year
11. American Pacific to Release Financial Results and Hold Fiscal 2008 First Quarter Investor Teleconference
Post Your Comments:
(Date:10/13/2015)... ... October 13, 2015 , ... ... kind product that targets the unique health needs of new moms. Postnatal ... Pregnancy Association ( ), utilizes Nordic Naturals’ exclusive, new, ultra-concentrated omega-3 ...
(Date:10/13/2015)... ... 2015 , ... California Southern University has named Dr. Judith ... Doctor of Nursing Practice from the renowned Johns Hopkins University—comes to CalSouthern with ... McLeod’s long and successful nursing practice included a variety of patient care, education ...
(Date:10/13/2015)... , ... October 13, 2015 , ... ... Bill Saye as the newest professional to introduce the latest development, ThermiVa® temperature ... recognized as a leading professional in Obstetrics and Gynecology and a pioneer in ...
(Date:10/13/2015)... ... October 13, 2015 , ... ... home furnishings and décor, today announced it closed on a $20.5 million funding ... will be used to support the Company’s continued rapid growth and expansion, broaden ...
(Date:10/13/2015)... ... 2015 , ... The Bill Howe Family of Companies is an award winning ... flood remediation services. Family-owned and operated for 35 years, they have maintained value, ethics ... plumber two years in a row from the Union Tribune Reader’s Poll, a Healthiest ...
Breaking Medicine News(10 mins):
(Date:10/13/2015)... 13, 2015  Yesterday Congresswoman Renee Ellmers ... manufacturing site located in Holly Springs, NC ... produced Flucelvax ® (Influenza Vaccine) using cell-culture technology, a ... start-up and is not reliant on chicken eggs. 1,2 ... influenza vaccines business of Novartis AG in the US, ...
(Date:10/12/2015)... -- Given the intricacy of the anatomy and ... an ophthalmic drug effectively to a specific ocular site. Several ... delivery. These include dilution of a drug by tears, clearance ... drug permeation issues with respect to the cornea, sclera and ... is lost due to the aforementioned barriers. --> ...
(Date:10/12/2015)... and CRANBURY, N.J. , Oct. ... LLP announces that a securities fraud class ... for the District of New Jersey.  The complaint alleges ... FOLD) violated the Securities Exchange Act of 1934 between ... materially false and misleading statements about Amicus Therapeutics, business ...
Breaking Medicine Technology: